Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 29, 2019	Dec. 30, 2018
Current assets:
Cash and cash equivalents	$ 2,042	$ 1,144
Short-term investments	1,372	2,368
Accounts receivable, net	573	514
Inventory	359	386
Prepaid expenses and other current assets	105	78
Total current assets	4,451	4,490
Property and equipment, net	889	1,075
Operating lease right-of-use assets	555
Goodwill	824	831
Intangible assets, net	145	185
Deferred tax assets, net	64	70
Other assets	388	308
Total assets	7,316	6,959
Current liabilities:
Accounts payable	149	184
Accrued liabilities	516	513
Long-term debt, current portion	0	1,107
Total current liabilities	665	1,804
Operating lease liabilities	695
Long-term debt	1,141	890
Other long-term liabilities	202	359
Commitments and contingencies
Redeemable noncontrolling interests	0	61
Stockholders’ equity:
Preferred stock, $0.01 par value, 10 million shares authorized; no shares issued and outstanding at December 29, 2019 and December 30, 2018	0	0
Common stock, $0.01 par value, 320 million shares authorized; 194 million shares issued and 147 million outstanding at December 29, 2019; 192 million shares issued and 147 million outstanding at December 30, 2018	2	2
Additional paid-in capital	3,560	3,290
Accumulated other comprehensive income (loss)	5	(1)
Retained earnings	4,067	3,083
Treasury stock, 47 million shares and 45 million shares at cost at December 29, 2019 and December 30, 2018, respectively	(3,021)	(2,616)
Total Illumina stockholders’ equity	4,613	3,758
Noncontrolling interests	0	87
Total stockholders’ equity	4,613	3,845
Total liabilities and stockholders’ equity	$ 7,316	$ 6,959